An antidepressant from the ’50s, repurposed to fight prostate cancer, lowered PSA levels in men with recurrent disease, pilot study shows.
Decades-old antidepressant may fend off prostate cancer’s return
An antidepressant from the ’50s, repurposed to fight prostate cancer, lowered PSA levels in men with recurrent disease, pilot study shows.